Canada · Health Canada Drug Product Database
CERVARIX
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 82773
- DIN
- 02342227
- Form
- Suspension
- Company as listed by source
- GLAXOSMITHKLINE INC
- Source status
- Marketed (2010-02-10)
- Source last updated
- 2026-06-15
Source-listed ingredients
- RECOMBINANT HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN — 20 MCG — per 0.5 ML
- RECOMBINANT HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN — 20 MCG — per 0.5 ML
These values do not establish equivalence or a dose recommendation.
Packages
- 0.5ml/10x0.5ml/100x0.5ml
Source and coverage
Open Health Canada Drug Product Database →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Canada records →